MGN-1706

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMGN-1706
Drug Alias NameMGN-17xxMGN-1706
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunomodulatorsToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMologen Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMologen Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A